Skip to content

Medical-device intelligence

QGT: Distal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine

FDA product code QGT: Distal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QGT
FDA device name
Distal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine
Device class
2
Regulation number
882.5899
Medical specialty
Neurology
Review panel
NE

FDA definition

A trunk and limb electrical stimulator to treat headache is a device intended to treat headache through the application of electrical stimulation anywhere on the body of the patient apart from the patient's head or neck through electrodes placed on the skin. The stimulation may be provided transcutaneously or percutaneously.
Explore neurology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

6 clearance records and 1 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Oct 23, 2020 to Mar 23, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202601
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

7 matching records
Device / recordCompany in FDA recordSourceSource date
Nerivio Infinity. Model/Catalog Number: FGD000100. Software Version: FW Version 4.1.2.0, App version 7.28.0.11Z-2855-2026 · QGTTHERANICA BIOELECTRONICS LTDRecallJul 31, 2026FDA classification date
Nerivio; Nerivio InfinityK250405 · QGTTheranica Bio-Electronics, Ltd.510(k)May 14, 2025FDA decision date
Nerivio; NerivioInfinityK241756 · QGTTheranica Bio-Electronics, Ltd.510(k)Oct 8, 2024FDA decision date
NerivioInfinityK232152 · QGTTheranica Bioelectronics , Ltd.510(k)Nov 8, 2023FDA decision date
NerivioK223169 · QGTTheranica Bioelectronics , Ltd.510(k)Feb 6, 2023FDA decision date
Nerivio, FGD000075-4.7K203181 · QGTTheranica Bioelectronics , Ltd.510(k)Jan 22, 2021FDA decision date
NerivioK201824 · QGTTheranica Bio-Electronics, Ltd.510(k)Oct 23, 2020FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗